Bank of New York Mellon »

C4 Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2023-12-31 $117k 21k 5.65
2023-09-30 $39k 21k 1.86
2023-06-30 $61k 22k 2.75
2023-03-31 $476k 152k 3.14
2022-12-31 $900k 153k 5.90
2022-09-30 $0 152k 0.00
2022-06-30 $1.0M 134k 7.55
2022-03-31 $3.1M 127k 24.27
2021-12-31 $4.0M 126k 32.19
2021-09-30 $5.0M 113k 44.67
2021-06-30 $3.2M 85k 37.83
2021-03-31 $1.1M 30k 36.97
2020-12-31 $939k 28k 33.15